menu
    • menu
    [{"orgOrder":0,"company":"Comercial Quimica Masso","sponsor":"Universit\u00e9 Catholique de Louvain","pharmaFlowCategory":"DU","therapeuticArea":"Sleep","country":"SPAIN","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Saffron Extract","moa":"Undisclosed","graph1":"Sleep","graph2":"Undisclosed","graph3":"Comercial Quimica Masso","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Sleep","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Comercial Quimica Masso \/ Universit\u00e9 Catholique de Louvain","highestDevelopmentStatusID":"1","companyTruncated":"Comercial Quimica Masso \/ Universit\u00e9 Catholique de Louvain"},{"orgOrder":0,"company":"Comercial Quimica Masso","sponsor":"Universit\u00e9 Catholique de Louvain","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"SPAIN","productType":"Plant Extract\/Herbal","year":"2023","type":"Inapplicable","leadProduct":"Saffron Extract","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"Comercial Quimica Masso","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Comercial Quimica Masso \/ Universit\u00e9 Catholique de Louvain","highestDevelopmentStatusID":"1","companyTruncated":"Comercial Quimica Masso \/ Universit\u00e9 Catholique de Louvain"},{"orgOrder":0,"company":"Entod Pharmaceuticals","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"INDIA","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Saffron Extract","moa":"Undisclosed","graph1":"Ophthalmology","graph2":"Approved FDF","graph3":"Entod Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Entod Pharmaceuticals \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Entod Pharmaceuticals \/ Undisclosed"},{"orgOrder":0,"company":"University of Alicante","sponsor":"Pharmactive Biotech Products S.L","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"SPAIN","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Saffron Extract","moa":"Undisclosed","graph1":"Ophthalmology","graph2":"Undisclosed","graph3":"University of Alicante","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Alicante \/ Pharmactive Biotech Products S.L","highestDevelopmentStatusID":"1","companyTruncated":"University of Alicante \/ Pharmactive Biotech Products S.L"},{"orgOrder":0,"company":"University of Alicante","sponsor":"Pharmactive Biotech Products S.L","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"SPAIN","productType":"Plant Extract\/Herbal","year":"2024","type":"Inapplicable","leadProduct":"Saffron Extract","moa":"Undisclosed","graph1":"Ophthalmology","graph2":"Undisclosed","graph3":"University of Alicante","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Alicante \/ Pharmactive Biotech Products S.L","highestDevelopmentStatusID":"1","companyTruncated":"University of Alicante \/ Pharmactive Biotech Products S.L"},{"orgOrder":0,"company":"Humanis","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Sleep","country":"TURKEY","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Saffron Extract","moa":"Undisclosed","graph1":"Sleep","graph2":"Approved FDF","graph3":"Humanis","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Sleep","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Humanis \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Humanis \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals for Saffron

    Menu

    Saffron

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            University of Alicante

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            University of Alicante

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Ophthalmology

                            Study Phase : Undisclosed

                            Sponsor : Pharmactive Biotech Products S.L

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome

                            Details : Saffron Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Dry Eye Syndromes.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            February 05, 2024

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Undisclosed

                            Sponsor : Pharmactive Biotech Products S.L

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Comercial Quimica Masso

                            Brazil arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Comercial Quimica Masso

                            Brazil arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Psychiatry/Psychology

                            Study Phase : Undisclosed

                            Sponsor : Université Catholique de Louvain

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluation of the Effect of a Combination of Plants to Regulate Mood

                            Details : Saffron Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Mood Regulation.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            November 18, 2023

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Undisclosed

                            Sponsor : Université Catholique de Louvain

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            University of Alicante

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            University of Alicante

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Ophthalmology

                            Study Phase : Undisclosed

                            Sponsor : Pharmactive Biotech Products S.L

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders

                            Details : Saffron Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Computer Vision Syndrome.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            January 27, 2022

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Undisclosed

                            Sponsor : Pharmactive Biotech Products S.L

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Entod Pharmaceuticals

                            India arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Entod Pharmaceuticals

                            India arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Ophthalmology

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            ENTOD Pharmaceuticals Introduces a Saffron based Eye Care Product in India to Promote Visual Performance

                            Details : MACUSAFF (Crocin), Manufactured from 100 percent DNA certified Persian origin natural saffron extract improves retinal flicker sensitivity, blood flow, protects RGC, reduce intraocular pressure and supports natural mechanisms of the eye is introduce in I...

                            Product Name : Macusaff

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            January 21, 2022

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Humanis

                            Turkey arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Humanis

                            Turkey arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Sleep

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            New Affron® Saffron Study Shows a Quick Effect on Sleep at Low Dosage

                            Details : The ingredient showed affron's effect in a single, low dose taken just one hour before bedtime, making affron a natural ingredient that is very easy to consume.

                            Product Name : Affron

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            August 31, 2021

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Sleep

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Comercial Quimica Masso

                            Brazil arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Comercial Quimica Masso

                            Brazil arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Sleep

                            Study Phase : Undisclosed

                            Sponsor : Université Catholique de Louvain

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluation of the Effects of Saffron Extract on Sleep Quality and Stress

                            Details : Saffron is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Sleep Initiation and Maintenance Disorders.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            February 11, 2021

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Sleep

                            Highest Development Status : Undisclosed

                            Sponsor : Université Catholique de Louvain

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth